As part of one of the key industry events – PHARMA 2026 – a presentation by the Head of Department, Dr. Sci. (Tech.), Professor Viktor Stabnikov was delivered, which went far beyond a purely scientific discussion. It was a conversation about the future. And about who shapes it and how.
It is worth noting: the very fact of inviting a representative of the academic community to participate in such a high-level professional platform is significant. This is recognition of the role of education in the development of the pharmaceutical industry and confirmation of NUFT’s status as one of the key higher education institutions that shapes the human resource potential for Ukraine’s biotechnological and pharmaceutical industry.
The main idea of Viktor Petrovych’s presentation was the thesis that biotechnology is not just a trend, but a point of responsibility. It is worth recognizing at the state level that today biotechnologies are not a “promising direction.” This is the foundation of new pharmaceuticals, a new economy, and a new quality of life. And the key question is no longer whether to develop biotechnologies, but whether we will manage to prepare people capable of working at this level.
In his presentation, Professor Stabnikov clearly outlined: without systemic integration of science, education, and production, this challenge cannot be overcome. A modern biotechnologist is not just a graduate with a diploma, but a specialist who works with real production cases, understands the requirements of the pharmaceutical market, possesses modern biotechnological tools, and is able to quickly adapt to innovative changes. And forming such a specialist in isolation is impossible.
That is why today it is critically important to unite the efforts of leading pharmaceutical enterprises, the scientific community, and higher education institutions. This is about creating a full-fledged educational and production environment in which a student gains access to modern equipment and technologies, participates in real research and production projects, develops practical skills that meet market requirements, and already during studies is immersed in an environment of innovation.
After all, today’s students are the ones who will determine the face of Ukrainian biopharmaceuticals tomorrow.
In the difficult conditions in which the country lives and works today, biotechnologies become not just a direction of development – they become an instrument of recovery and growth.
And that is why such discussions at the level of PHARMA 2026 are not just an exchange of views. This is the formation of a shared vision.
Professor Stabnikov’s presentation was another important reminder that the future of biotechnology is not created separately in laboratories or production, it is born at the intersection of cooperation, trust, and shared responsibility. And most importantly, it begins with education that provides not just knowledge, but the ability to act.



